Formycon AG (XTER:FYB) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Revenue Challenges

By Yahoo! Finance   |   1 year ago
Formycon AG (XTER:FYB) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Revenue Challenges

Formycon CEO Stefan Glombitza highlighted their strong position in the legal dispute, alongside major players like Amgen. They expect a favorable outcome despite market share fluctuations and are confident in launching FYB202 with Fresenius Kabi in the US by February 2025.

Read More

Did you find this insightful?